0001410384-19-000141.txt : 20191125 0001410384-19-000141.hdr.sgml : 20191125 20191125164244 ACCESSION NUMBER: 0001410384-19-000141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191122 FILED AS OF DATE: 20191125 DATE AS OF CHANGE: 20191125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Offerdahl James CENTRAL INDEX KEY: 0001490198 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36350 FILM NUMBER: 191246661 MAIL ADDRESS: STREET 1: 11501 DOMAIN DRIVE STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q2 Holdings, Inc. CENTRAL INDEX KEY: 0001410384 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202706637 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 BUSINESS PHONE: 512-275-0072 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings, Inc. DATE OF NAME CHANGE: 20120103 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings Inc DATE OF NAME CHANGE: 20070821 4 1 wf-form4_157471814639570.xml FORM 4 X0306 4 2019-11-22 0 0001410384 Q2 Holdings, Inc. QTWO 0001490198 Offerdahl James 13785 RESEARCH BLVD. SUITE 150 AUSTIN TX 78750 1 0 0 0 Common Stock 2019-11-22 4 M 0 10865 4 A 19258 D Common Stock 2019-11-22 4 M 0 4135 13 A 23393 D Common Stock 2019-11-22 4 S 0 15000 82.21 D 8393 D Stock Option (right to buy) 4.0 2019-11-22 4 M 0 10865 0 D 2013-02-08 2022-02-08 Common Stock 10865.0 0 D Stock Option (right to buy) 13.0 2019-11-22 4 M 0 4135 0 D 2014-04-19 2024-03-19 Common Stock 4135.0 5480 D Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.805 to $82.84 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option grant vested as to 1/4 of the total option grant on February 8, 2013, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests The option grant vested and becomes exercisable in equal monthly installments over 36 months beginning on April 19, 2014. /s/ M. Scott Kerr, attorney-in-fact 2019-11-25